GENEVA, Nov. 11 -- OBI PHARMA, INC. (6F., No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist.,Taipei City, 115011), WANG, Hwei-Gene (6F., No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist.,Taipei City, 115011) filed a patent application (PCT/US2025/026725) for "IMPROVED LINKER-PAYLOADS FOR ANTIBODY CONJUGATION, PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS THEREOF" on Apr 29, 2025. With publication no. WO/2025/230926, the details related to the patent application was published on Nov 06, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): LAI, Ming-Tain (6F., No. 508, Sec. 7, Zhongxiao E. Rd., Nangang...